Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Management
Volume 18, Issue 3, Pages 119-126
http://dx.doi.org/10.1155/2013/918216
Original Article

2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome: Executive Summary

Mary-Ann Fitzcharles,1,2 Peter A Ste-Marie,2,3 Don L Goldenberg,4 John X Pereira,5 Susan Abbey,6 Manon Choinière,7 Gordon Ko,8 Dwight E Moulin,9 Pantelis Panopalis,1 Johanne Proulx,10 Yoram Shir,2 and the National Fibromyalgia Guideline Advisory Panel

1Division of Rheumatology, McGill University, Canada
2Alan Edwards Pain Management Unit, McGill University Health Centre, Canada
3Faculty of Law, Université de Montréal, Montreal, Quebec, Canada
4Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA
5Department of Family Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
6Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
7Centre de la recherche du Centre hospitalier de l’Université de Montréal, Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada
8Division of Physiatry, University of Toronto, Toronto, Canada
9Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada
10Patient representative, Canada

Copyright © 2013 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [132 citations]

The following is the list of published articles that have cited the current article.

  • Seungree Nam, Diane Tin, Lorna Bain, J. Carter Thorne, and Liane Ginsburg, “Clinical utility of the Hospital Anxiety and Depression Scale (HADS) for an Outpatient Fibromyalgia Education Program,” Clinical Rheumatology, 2013. View at Publisher · View at Google Scholar
  • Mary-Ann Fitzcharles, Peter A. Ste-Marie, Yoram Shir, Mary-Ann Fitzcharles, Peter A. Ste-Marie, and Yoram Shir, “Work-related Physical Trauma and Fibromyalgia Reply,” Journal Of Rheumatology, vol. 40, no. 9, pp. 1622–1623, 2013. View at Publisher · View at Google Scholar
  • William Collinge, Paul Yarnold, and Robert Soltysik, “Fibromyalgia symptom reduction by online behavioral self-monitoring, longitudinal single subject analysis and automated delivery of individualized guidance,” North American Journal of Medical Sciences, vol. 5, no. 9, pp. 546–553, 2013. View at Publisher · View at Google Scholar
  • Winfried Haeuser, Jacob Ablin, Mary-Ann Fitzcharles, Dan Buskila, Yoram Shir, Claudia Sommer, Winfried Haeuser, Jacob Ablin, Mary-Ann Fitzcharles, Dan Buskila, Yoram Shir, and Claudia Sommer, “Treatment of Fibromyalgia Syndrome: Recommendations of Recent Evidence-Based Interdisciplinary Guidelines with Special Emphasis on Complementary and A,” Evidence-Based Complementary And Alternative Medicine, 2013. View at Publisher · View at Google Scholar
  • Mary-Ann Fitzcharles, Yoram Shir, Jacob N. Ablin, Dan Buskila, Howard Amital, Peter Henningsen, Winfried Haeuser, Mary-Ann Fitzcharles, Yoram Shir, Jacob N. Ablin, Dan Buskila, Howard Amital, Peter Henningsen, and Winfried Haeuser, “Classification and Clinical Diagnosis of Fibromyalgia Syndrome: Recommendations of Recent Evidence-Based Interdisciplinary Guidelines,” Evidence-Based Complementary And Alternative Medicine, 2013. View at Publisher · View at Google Scholar
  • Roberto P. Benzo, Mary O. Whipple, Samantha J. McAllister, Patricia J. Erwin, and Leorey N. Saligan, “Beyond pain in fibromyalgia: insights into the symptom of fatigue,” Arthritis Research & Therapy, vol. 15, no. 6, 2013. View at Publisher · View at Google Scholar
  • Kathrin Bernardy, Petra Klose, Angela J. Busch, and Ernest H. S. Choy, “Cognitive behavioural therapies for fibromyalgia,” Cochrane Database of Systematic Reviews, no. 9, 2013. View at Publisher · View at Google Scholar
  • Lazslo A. Avila, Gerardo M. de Araujo Filho, Estefano F. U. Guimaraes, Lauro C. S. Goncalves, Paola N. Paschoalin, Fabia B. Aleixo, Lazslo A. Avila, Gerardo M. de Araujo Filho, Estefano F. U. Guimaraes, Lauro C. S. Goncalves, Paola N. Paschoalin, and Fabia B. Aleixo, “Characterization of the pain, sleep and alexithymia patterns of patients with fibromyalgia treated in a Brazilian tertiary center,” Revista Brasileira De Reumatologia, vol. 54, no. 5, 2014. View at Publisher · View at Google Scholar
  • Lazslo A. Avila, Gerardo M. de Araujo Filho, Estefano F.U. Guimarães, Lauro C.S. Gonçalves, Paola N. Paschoalin, and Fabia B. Aleixo, “Characterization of the pain, sleep and alexithymia patterns of patients with fibromyalgia treated in a Brazilian tertiary center,” Revista Brasileira de Reumatologia (English Edition), vol. 54, no. 5, pp. 409–413, 2014. View at Publisher · View at Google Scholar
  • Catharina Sadaghiani, and Johannes Naumann, “Therapeutic benefit of balneotherapy and hydrotherapy in the management of fibromyalgia syndrome: A qualitative systematic review and meta-analysis of randomized controlled trials,” Arthritis Research and Therapy, vol. 16, no. 4, 2014. View at Publisher · View at Google Scholar
  • Mary-Ann Fitzcharles, Emmanowl Rampakakis, Peter A. Ste-Marie, John S. Sampalis, and Yoram Shir, “The Association of Socioeconomic Status and Symptom Severity in Persons with Fibromyalgia,” Journal of Rheumatology, vol. 41, no. 7, pp. 1398–1404, 2014. View at Publisher · View at Google Scholar
  • M. -A. Fitzcharles, P. A. Ste-Marie, Y. Shir, M. -A. Fitzcharles, P. A. Ste-Marie, and Y. Shir, “Medicolegal Implications Of The 2012 Canadian Fibromyalgia Guidelines,” Annals Of The Rheumatic Diseases, vol. 73, pp. 1085–1086, 2014. View at Publisher · View at Google Scholar
  • Roberto Garrastazu López, Guillermo Basauri Camiruaga, Ana Viejo Casas, Susana Conde Díaz, and Mario Ruiz Núñez, “¿Qué aporta la homeopatía en la fibromialgia? Revisión y experiencia con una serie de casos,” Revista Médica de Homeopatía, vol. 7, no. 2, pp. 90–96, 2014. View at Publisher · View at Google Scholar
  • Daniel J. Clauw, and Daniel J. Clauw, “Fibromyalgia A Clinical Review,” Jama-Journal Of The American Medical Association, vol. 311, no. 15, pp. 1547–1555, 2014. View at Publisher · View at Google Scholar
  • Paul S. Tumber, and Paul S. Tumber, “Optimizing perioperative analgesia for the complex pain patient: medical and interventional strategies,” Canadian Journal Of Anesthesia-Journal Canadien D Anesthesie, vol. 61, no. 2, pp. 131–140, 2014. View at Publisher · View at Google Scholar
  • Bente Danneskiold-Samsøe, Else Marie Bartels, Bente Danneskiold-Samsøe, and Else Marie BartelsNovel Insights into the Pathophysiology and Treatment of Fibromyalgia, pp. 6–13, 2014. View at Publisher · View at Google Scholar
  • Peter A. Ste-Marie, Angela Mailis, Mary-Ann Fitzcharles, and Yoram Shir, “Adjudication of fibromyalgia syndrome: Challenges in the medicolegal arena,” Pain Research and Management, vol. 19, no. 6, pp. 287–292, 2014. View at Publisher · View at Google Scholar
  • Warren R. Nielson, and Manfred Harth, “Fibromyalgia and disability adjudication: No simple solutions to a complex problem,” Pain Research and Management, vol. 19, no. 6, pp. 293–299, 2014. View at Publisher · View at Google Scholar
  • L. A. VanderWeide, S. M. Smith, and K. E. Trinkley, “A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia,” Journal of Clinical Pharmacy and Therapeutics, 2014. View at Publisher · View at Google Scholar
  • Mary-Ann Fitzcharles, Peter A. Ste-Marie, Yoram Shir, David Lussier, Mary-Ann Fitzcharles, Peter A. Ste-Marie, Yoram Shir, and David Lussier, “Management of Fibromyalgia in Older Adults,” Drugs & Aging, vol. 31, no. 10, pp. 711–719, 2014. View at Publisher · View at Google Scholar
  • Jana Sawynok, and Mary Lynch, “Qigong and Fibromyalgia: Randomized Controlled Trials and Beyond,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Brian Walitt, Mary-Ann Fitzcharles, and Claudia Sommer, “Review of pharmacological therapies in fibromyalgia syndrome,” Arthritis Research & Therapy, vol. 16, no. 1, 2014. View at Publisher · View at Google Scholar
  • Şule Şahin Onat, Sibel Oz̈budak Demir, Sumru Özel, and Sibel Ünsal Delialioǧlu, “The prevalence of fibromyalgia in postmenopausal osteoporotic women and to determination of related risk factors (preliminary study),” Turk Osteoporoz Dergisi, vol. 20, no. 1, pp. 1–5, 2014. View at Publisher · View at Google Scholar
  • Kenji Sanada, Marta Alda Diez, Montserrat Salas Valero, Maria Cruz Perez-Yus, Marcelo M. P. Demarzo, Mauro Garcia-Toro, and Javier Garcia-Campayo, “Effects of non-pharmacological interventions on inflammatory biomarker expression in patients with fibromyalgia: a systematic review,” Arthritis Research & Therapy, vol. 17, 2015. View at Publisher · View at Google Scholar
  • M. Gomez-Calvente, I. Medina-Porqueres, A. Fontalba-Navas, J. M. Pena-Andreu, C. de Vos-Martin, M. Gomez-Calvente, I. Medina-Porqueres, A. Fontalba-Navas, J. M. Pena-Andreu, and C. de Vos-Martin, “Validation and cross-cultural adaptation of the 'Fibromyalgia Participation Questionnaire' to the Spanish population: study protocol,” Rheumatology International, vol. 35, no. 9, pp. 1609–1613, 2015. View at Publisher · View at Google Scholar
  • Teresa Maria Seccia, Giacomo Rossitto, Lorenzo A. Calo, Gian Paolo Rossi, Teresa Maria Seccia, Giacomo Rossitto, Lorenzo A. Calo, and Gian Paolo Rossi, “Oral Burning With Dysphagia and Weight Loss,” Medicine, vol. 94, no. 31, 2015. View at Publisher · View at Google Scholar
  • Donald A. Redelmeier, Jeremy D. Zung, Deva Thiruchelvam, Robert J. Tibshirani, Donald A. Redelmeier, Jeremy D. Zung, Deva Thiruchelvam, and Robert J. Tibshirani, “Fibromyalgia and the Risk of a Subsequent Motor Vehicle Crash,” Journal Of Rheumatology, vol. 42, no. 8, pp. 1502–1510, 2015. View at Publisher · View at Google Scholar
  • Alfonse T. Masi, and Ann Vincent, “A historical and clinical perspective endorsing person-centered management of fibromyalgia syndrome,” Current Rheumatology Reviews, vol. 11, no. 2, pp. 86–95, 2015. View at Publisher · View at Google Scholar
  • Winfried Häuser, Petra Klose, Nurcan Üçeyler, and Brian WalittCochrane Database of Systematic Reviews, 2015. View at Publisher · View at Google Scholar
  • Eugene Hsu, and Srdjan S. Nedeljkovic, “Utilizing Clinical Treatments with a Limited Evidence Base,” Fibromyalgia, pp. 129–138, 2015. View at Publisher · View at Google Scholar
  • M. Guinot, S. Launois, A. Favre-Juvin, and C. Maindet-Dominici, “Fibromialgia: fisiopatologia e accompagnamento terapeutico,” EMC - Medicina Riabilitativa, vol. 22, no. 2, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand, and Chi-Un Pae, “Fibromyalgia diagnosis: a review of the past, present and future,” Expert Review of Neurotherapeutics, vol. 15, no. 6, pp. 667–679, 2015. View at Publisher · View at Google Scholar
  • Elena P. Calandre, Fernando Rico-Villademoros, and Mahmoud Slim, “An update on pharmacotherapy for the treatment of fibromyalgia,” Expert Opinion On Pharmacotherapy, vol. 16, no. 9, pp. 1347–1368, 2015. View at Publisher · View at Google Scholar
  • Patricia Bourgault, Anaïs Lacasse, Serge Marchand, Roxanne Courtemanche-Harel, Jacques Charest, Isabelle Gaumond, Juliana Barcellos de Souza, and Manon Choinière, “Multicomponent Interdisciplinary Group Intervention for Self-Management of Fibromyalgia: A Mixed-Methods Randomized Controlled Trial,” Plos One, vol. 10, no. 5, pp. e0126324, 2015. View at Publisher · View at Google Scholar
  • Eric P. Baron, “Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …,” Headache: The Journal of Head and Face Pain, 2015. View at Publisher · View at Google Scholar
  • Daniel J. Clauw, and Daniel J. Clauw, “Fibromyalgia and Related Conditions,” Mayo Clinic Proceedings, vol. 90, no. 5, pp. 680–692, 2015. View at Publisher · View at Google Scholar
  • Winfried Häuser, Brian Walitt, Petra Klose, and Mary-Ann FitzcharlesCochrane Database of Systematic Reviews, 2015. View at Publisher · View at Google Scholar
  • M. Guinot, S. Launois, A. Favre-Juvin, and C. Maindet-Dominici, “Fibromialgia: fisiopatología y apoyo terapéutico,” EMC - Kinesiterapia - Medicina Física, vol. 36, no. 2, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • F. Laroche, and J. Guérin, “Fibromyalgie : où en est-on en 2015 ?,” Douleur et Analgésie, vol. 28, no. 1, pp. 31–39, 2015. View at Publisher · View at Google Scholar
  • Jacob N. Ablin, Dan Buskila, Jacob N. Ablin, and Dan Buskila, “"Real-life" treatment of chronic pain: Targets and goals,” Best Practice & Research In Clinical Rheumatology, vol. 29, no. 1, pp. 111–119, 2015. View at Publisher · View at Google Scholar
  • Rachel Halpern, Sonali N. Shah, Joseph C. Cappelleri, Elizabeth T. Masters, and Andrew Clair, “Evaluating Guideline-recommended Pain Medication Use Among Patients with Newly Diagnosed Fibromyalgia,” Pain Practice, 2015. View at Publisher · View at Google Scholar
  • Fernando Rico-Villademoros, Mahmoud Slim, and Elena P. Calandre, “Amitriptyline for the treatment of fibromyalgia: a comprehensive review,” Expert Review Of Neurotherapeutics, vol. 15, no. 10, pp. 1123–1150, 2015. View at Publisher · View at Google Scholar
  • Howard M. Kravitz, and Robert S. Katz, “Fibrofog and fibromyalgia: a narrative review and implications for clinical practice,” Rheumatology International, 2015. View at Publisher · View at Google Scholar
  • Julius Bourke, and Julius Bourke, “Fibromyalgia and Chronic Fatigue Syndrome: Management Issues,” Clinical Challenges In The Biopsychosocial Interface: Update On Psychosomatics For The 21St Century, vol. 34, pp. 78–91, 2015. View at Publisher · View at Google Scholar
  • Sheena Derry, Malene Cording, Philip J Wiffen, Simon Law, Tudor Phillips, and R Andrew MooreCochrane Database of Systematic Reviews, 2016. View at Publisher · View at Google Scholar
  • Helen Gaskell, R Andrew Moore, Sheena Derry, and Cathy StannardCochrane Database of Systematic Reviews, 2016. View at Publisher · View at Google Scholar
  • Angela Starkweather, and Victoria Menzies, “Fibromyalgia,” Topics in Pain Management, vol. 32, no. 2, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  • Lesley M. Arnold, Ernest Choy, Daniel J. Clauw, Don L. Goldenberg, Richard E. Harris, Milton Helfenstein, Troels Staehelin Jensen, Koichi Noguchi, Stuart L. Silverman, Takahiro Ushida, and Guochun Wang, “Fibromyalgia and Chronic Pain Syndromes,” The Clinical Journal of Pain, vol. 32, no. 9, pp. 737–746, 2016. View at Publisher · View at Google Scholar
  • Stéphane Potvin, and Serge Marchand, “Pain facilitation and pain inhibition during conditioned pain modulation in fibromyalgia and in healthy controls,” Pain, vol. 157, no. 8, pp. 1704–1710, 2016. View at Publisher · View at Google Scholar
  • Sheena Derry, Philip J Wiffen, Winfried Häuser, Martin Mücke, Thomas Rudolf Tölle, Rae F Bell, and R Andrew MooreCochrane Database of Systematic Reviews, 2016. View at Publisher · View at Google Scholar
  • Michael E Hyland, Claire Hinton, Charlotte Hill, Ben Whalley, Rupert CM Jones, and Anthony F Davies, “Explaining unexplained pain to fibromyalgia patients: finding a narrative that is acceptable to patients and provides a rationale for evidence based interventions,” British Journal of Pain, vol. 10, no. 3, pp. 156–161, 2016. View at Publisher · View at Google Scholar
  • Brian Walitt, Petra Klose, Mary-Ann Fitzcharles, Tudor Phillips, and Winfried HäuserCochrane Database of Systematic Reviews, 2016. View at Publisher · View at Google Scholar
  • Ian Gilron, Luis E. Chaparro, Dongsheng Tu, Ronald R. Holden, Roumen Milev, Tanveer Towheed, Deborah DuMerton-Shore, and Sarah Walker, “Combination of pregabalin with duloxetine for fibromyalgia,” Pain, vol. 157, no. 7, pp. 1532–1540, 2016. View at Publisher · View at Google Scholar
  • Gregory Thorkelson, Klaus Bielefeldt, and Eva Szigethy, “Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD,” Inflammatory Bowel Diseases, vol. 22, no. 6, pp. 1509–1522, 2016. View at Publisher · View at Google Scholar
  • Steven Stanos, Marina Brodsky, Charles Argoff, Daniel J. Clauw, Yvonne D'Arcy, Sean Donevan, Kevin B. Gebke, Mark P. Jensen, Evelyn Lewis Clark, Bill McCarberg, Peter W. Park, Dennis C. Turk, and Stephen Watt, “Rethinking chronic pain in a primary care setting,” Postgraduate Medicine, vol. 128, no. 5, pp. 502–515, 2016. View at Publisher · View at Google Scholar
  • Brian Walitt, Petra Klose, Nurcan Üçeyler, Tudor Phillips, and Winfried HäuserCochrane Database of Systematic Reviews, 2016. View at Publisher · View at Google Scholar
  • Juan A. Ramos, “The Great Deceiver,” A & A Case Reports, vol. 6, no. 11, pp. 364–365, 2016. View at Publisher · View at Google Scholar
  • Annie Palstam, Anette Larsson, Monika Löfgren, Malin Ernberg, Jan Bjersing, Indre Bileviciute-Ljungar, Björn Gerdle, Eva Kosek, and Kaisa Mannerkorpi, “Decrease of fear avoidance beliefs following person-centered progressive resistance exercise contributes to reduced pain disability in women with fibromyalgia: secondary exploratory analyses from a randomized controlled trial,” Arthritis Research & Therapy, vol. 18, no. 1, 2016. View at Publisher · View at Google Scholar
  • Angela J. Tefft, and Irma O. Jordan, “Eye Movement Desensitization Reprocessing as Treatment for Chronic Pain Syndromes,” Journal of the American Psychiatric Nurses Association, vol. 22, no. 3, pp. 192–214, 2016. View at Publisher · View at Google Scholar
  • Mary-Ann Fitzcharles, John S. Sampalis, Yoram Shir, Peter A. Ste-Marie, and Emmanouil Rampakakis, “Disability in fibromyalgia associates with symptom severity and occupation characteristics,” Journal of Rheumatology, vol. 43, no. 5, pp. 931–936, 2016. View at Publisher · View at Google Scholar
  • Don L. Goldenberg, Daniel J. Clauw, Roy E. Palmer, and Andrew G. Clair, “Opioid Use in Fibromyalgia,” Mayo Clinic Proceedings, vol. 91, no. 5, pp. 640–648, 2016. View at Publisher · View at Google Scholar
  • Wen-Hsuan Hou, Tzu-Ya Wang, and Jiunn-Horng Kang, “The effects of add-on non-invasive brain stimulation in fibromyalgia: a meta-analysis and meta-regression of randomized controlled trials,” Rheumatology, pp. kew205, 2016. View at Publisher · View at Google Scholar
  • Anaïs Lacasse, Patricia Bourgault, and Manon Choinière, “Fibromyalgia-related costs and loss of productivity: a substantial societal burden,” BMC Musculoskeletal Disorders, vol. 17, no. 1, 2016. View at Publisher · View at Google Scholar
  • Mercedes Sarudiansky, “Análisis temático sobre la fibromialgia en la prensa escrita Argentina: descripciones generales y el rol de la psicología,” Interface - Comunicação, Saúde, Educação, vol. 20, no. 56, pp. 25–36, 2016. View at Publisher · View at Google Scholar
  • Raúl Jesús Regal Ramos, “Fibromialgia: hipotiroidismo o trastorno de dolor persistente somatomorfo,” Medicina General y de Familia, 2016. View at Publisher · View at Google Scholar
  • Daniel Ángel García, Ismael Martínez Nicolás, and Pedro J. Saturno Hernández, “«Abordaje clínico de la fibromialgia: síntesis de recomendaciones basadas en la evidencia, una revisión sistemática»,” Reumatología Clínica, vol. 12, no. 2, pp. 65–71, 2016. View at Publisher · View at Google Scholar
  • Daniel Ángel García, Ismael Martínez Nicolás, and Pedro J. Saturno Hernández, ““Clinical Approach to Fibromyalgia: Synthesis of Evidence-based Recommendations, a Systematic Review”,” Reumatología Clínica (English Edition), vol. 12, no. 2, pp. 65–71, 2016. View at Publisher · View at Google Scholar
  • R.J. Regal Ramos, “Características epidemiológicas de los pacientes evaluados por fibromialgia en la Unidad Médica de Valoración de Incapacidades de Madrid,” SEMERGEN - Medicina de Familia, 2016. View at Publisher · View at Google Scholar
  • Corey C. Tsang, and Mirella G. Giudice, “Nabilone for the Management of Pain,” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 36, no. 3, pp. 273–286, 2016. View at Publisher · View at Google Scholar
  • Joseph Bernstein, and Joseph Bernstein, “Not the Last Word: Fibromyalgia is Real,” Clinical Orthopaedics And Related Research, vol. 474, no. 2, pp. 304–309, 2016. View at Publisher · View at Google Scholar
  • Maria Chiara Gerardi, Alberto Batticciotto, Rossella Talotta, Manuela Di Franco, Fabiola Atzeni, and Piercarlo Sarzi-Puttini, “Novel pharmaceutical options for treating fibromyalgia,” Expert Review of Clinical Pharmacology, vol. 9, no. 4, pp. 559–565, 2016. View at Publisher · View at Google Scholar
  • Santosh Bhusal, Marina N. Magrey, and Sherilyn Diomampo, “Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia,” Drug, Healthcare and Patient Safety, vol. 8, pp. 13–23, 2016. View at Publisher · View at Google Scholar
  • Kati Thieme, Marc Mathys, and Dennis C. Turk, “Evidenced-Based Guidelines on the Treatment of Fibromyalgia Patients: Are They Consistent and If Not, Why Not? Have Effective Psychological Treatments Been Overlooked?,” The Journal of Pain, 2016. View at Publisher · View at Google Scholar
  • Caroline P. Schaefer, Roland Staud, Edgar H. Adams, Elizabeth T. Masters, Heather J. McElroy, Markay Hopps, Philip Mease, Stuart L. Silverman, Margarita Udall, Rachael M. Mann, Shoshana R. Daniel, Joseph C. Cappelleri, and Andrew G. Clair, “Fibromyalgia outcomes over time: Results from a prospective observational study in the United States,” Open Rheumatology Journal, vol. 10, pp. 109–121, 2016. View at Publisher · View at Google Scholar
  • Elizabeth T. Masters, Joseph C. Cappelleri, Jay M. Margolis, David M. Smith, and Steven Faulkner, “Evaluating increased resource use in fibromyalgia using electronic health records,” ClinicoEconomics and Outcomes Research, vol. 8, pp. 675–683, 2016. View at Publisher · View at Google Scholar
  • Judith A. Turner, Susan M. Shortreed, Kathleen W. Saunders, Linda LeResche, Stephen Thielke, and Michael Von Korff, “Does association of opioid use with pain and function differ by fibromyalgia or widespread pain status?,” Pain, vol. 157, no. 10, pp. 2208–2216, 2016. View at Publisher · View at Google Scholar
  • Daniel Whibley, Linda E. Dean, and Neil Basu, “Management of Widespread Pain and Fibromyalgia,” Current Treatment Options in Rheumatology, 2016. View at Publisher · View at Google Scholar
  • M.-A. Fitzcharles, C. Baerwald, J. Ablin, and W. Häuser, “Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis),” Der Schmerz, 2016. View at Publisher · View at Google Scholar
  • Jessica Robinson-Papp, “HIV and chronic pain: musculoskeletal pain,” Chronic Pain and HIV, pp. 27–37, 2016. View at Publisher · View at Google Scholar
  • Victoria Menzies, and Victoria Menzies, “Fibromyalgia Syndrome: Current Considerations in Symptom Management,” American Journal Of Nursing, vol. 116, no. 1, pp. 24–32, 2016. View at Publisher · View at Google Scholar
  • Kirstine Amris, George Luta, Robin Christensen, Bente Danneskiold-Samsoe, Henning Bliddal, and Eva E. Waehrens, “Predictors Of Improvement In Observed Functional Ability In Patients With Fibromyalgia As An Outcome Of Rehabilitation,” Journal Of Rehabilitation Medicine, vol. 48, no. 1, pp. 65–71, 2016. View at Publisher · View at Google Scholar
  • April F. Mohanty, Drew A. Helmer, Anusha Muthukutty, Lisa M. McAndrew, Marjorie E. Carter, Joshua Judd, Jennifer H. Garvin, Matthew H. Samore, and Adi V. Gundlapalli, “Fibromyalgia syndrome care of Iraq- and Afghanistan-deployed Veterans in Veterans Health Administration,” Journal of Rehabilitation Research and Development, vol. 53, no. 1, 2016. View at Publisher · View at Google Scholar
  • Erdem İlgün, Fethi Demir, Mehmet Demirayak, Ömer Akyürek, Ali Osman Kalkan, and Mustafa Bilgi, “Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in fibromyalgia,” European Journal of General Medicine, vol. 13, no. 2, pp. 100–104, 2016. View at Publisher · View at Google Scholar
  • Yasser El Miedany, Maha El Gaafary, Sally Youssef, and Ihab Ahmed, “Towards Tailored Patient’s Management Approach: Integrating the Modified 2010 ACR Criteria for Fibromyalgia in Multidimensional Patient Reported Outcome Measures Questionnaire,” Arthritis, vol. 2016, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Pilar Montesó-Curto, Montserrat García-Martinez, Sara Romaguera, María Luisa Mateu, María Teresa Cubí-Guillén, Lidia Sarrió-Colas, Anna Núria Llàdser, Stephen Bradley, and María Luisa Panisello-Chavarria, “Problems and solutions for patients with fibromyalgia: Building new helping relationships,” Journal of Advanced Nursing, 2017. View at Publisher · View at Google Scholar
  • Winfried Häuser, Serge Perrot, Daniel J. Clauw, and Mary-Ann Fitzcharles, “Unravelling Fibromyalgia – Steps Towards Individualized Management,” The Journal of Pain, 2017. View at Publisher · View at Google Scholar
  • Julia Bidonde, Angela J Busch, Ina van der Spuy, Susan Tupper, Soo Y Kim, and Catherine Boden, “Whole body vibration exercise training for fibromyalgia,” Cochrane Database of Systematic Reviews, 2017. View at Publisher · View at Google Scholar
  • Francisco Buitrago Ramírez, Manuel Tejero Mas, Cristina Gato Núñez, Nuria Rivera Jiménez, and Francisco Luis Pérez Caballero, “Abordaje integrado de la fibromialgia,” FMC - Formación Médica Continuada en Atención Primaria, vol. 24, no. 7, pp. 395–404, 2017. View at Publisher · View at Google Scholar
  • Lilo Fink, and Deborah Lewis, “Exercise as a Treatment for Fibromyalgia: A Scoping Review,” The Journal for Nurse Practitioners, 2017. View at Publisher · View at Google Scholar
  • Ian Gilron, Dongsheng Tu, Ronald Holden, Tanveer Towheed, Elizabeth Vandenkerkhof, and Roumen Milev, “Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain,” JMIR Research Protocols, vol. 6, no. 8, pp. e154, 2017. View at Publisher · View at Google Scholar
  • Rosalind Gittins, Molly Howard, Ameer Ghodke, Timothy J. Ives, and Paul Chelminski, “The Accuracy of a Fibromyalgia Diagnosis in General Practice,” Pain Medicine, 2017. View at Publisher · View at Google Scholar
  • Lesley M. Arnold, and Daniel J. Clauw, “Challenges of implementing fibromyalgia treatment guidelines in current clinical practice,” Postgraduate Medicine, pp. 1–6, 2017. View at Publisher · View at Google Scholar
  • Patrick Welsch, Kathrin Bernardy, Sheena Derry, R Andrew Moore, and Winfried HäuserCochrane Database of Systematic Reviews, 2017. View at Publisher · View at Google Scholar
  • W. Häuser, and M. Nothacker, “Methodenreport der Leitlinie 2017 zum Fibromyalgiesyndrom,” Der Schmerz, 2017. View at Publisher · View at Google Scholar
  • Sabrina Gmuca, and David D. Sherry, “Fibromyalgia: Treating Pain in the Juvenile Patient,” Pediatric Drugs, 2017. View at Publisher · View at Google Scholar
  • Sanam Kia, and Ernet Choy, “Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology,” Biomedicines, vol. 5, no. 2, pp. 20, 2017. View at Publisher · View at Google Scholar
  • Jacob N. Ablin, Iris Eshed, Mark Berman, Valerie Aloush, Irena Wigler, Dan Caspi, Maria Likhter, Jonathan Wollman, Daphna Paran, Marina Anouk, and Ori Elkayam, “Prevalence of Axial Spondyloarthritis Among Patients With Fibromyalgia: A Magnetic Resonance Imaging Study With Application of the Assessment of SpondyloArthritis International Society Classification Criteria,” Arthritis Care & Research, vol. 69, no. 5, pp. 724–729, 2017. View at Publisher · View at Google Scholar
  • Amy Peterman, and Charlsie Myers, “Fibromyalgia,” Encyclopedia of Clinical Neuropsychology, pp. 1–5, 2017. View at Publisher · View at Google Scholar
  • Sheena Derry, Philip J Wiffen, Winfried Häuser, Martin Mücke, Thomas Rudolf Tölle, Rae F Bell, and R Andrew MooreCochrane Database of Systematic Reviews, 2017. View at Publisher · View at Google Scholar
  • W.A. Sifuentes-Giraldo, and J.L. Morell-Hita, “Fibromialgia,” Medicine - Programa de Formación Médica Continuada Acreditado, vol. 12, no. 27, pp. 1586–1595, 2017. View at Publisher · View at Google Scholar
  • Herman Kwok, Wayne Khuu, Kimberly Fernandes, Diana Martins, Mina Tadrous, Samantha Singh, David N. Juurlink, and Tara Gomes, “Impact of Unrestricted Access to Pregabalin on the Use of Opioids and Other CNS-Active Medications: A Cross-Sectional Time Series Analysis,” Pain Medicine, 2017. View at Publisher · View at Google Scholar
  • Helen Cohen, “Controversies and challenges in fibromyalgia: a review and a proposal,” Therapeutic Advances in Musculoskeletal Disease, vol. 9, no. 5, pp. 115–127, 2017. View at Publisher · View at Google Scholar
  • David M. Smith, Lucy Abraham, Joseph C. Cappelleri, Peter W. Park, Jay M. Margolis, Nicole Princic, and Sonali N. Shah, “Development of a novel algorithm to determine adherence to chronic pain treatment guidelines using administrative claims,” Journal of Pain Research, vol. 10, pp. 327–339, 2017. View at Publisher · View at Google Scholar
  • Florence B. Pomares, Mary-Ann Fitzcharles, Petra Schweinhardt, Marta Ceko, Alexander Thiel, Nikola Stikov, Thomas Funck, Natasha A. Feier, Steven Roy, Alexandre Daigle-Martel, Sridar Narayanan, and David Araujo, “Histological underpinnings of grey matter changes in fibromyalgia investigated using multimodal brain imaging,” Journal of Neuroscience, vol. 37, no. 5, pp. 1090–1101, 2017. View at Publisher · View at Google Scholar
  • Fabiola Atzeni, Maria Chiara Gerardi, Ignazio Francesco Masala, Alessandra Alciati, Alberto Batticciotto, and Piercarlo Sarzi-Puttini, “An update on emerging drugs for fibromyalgia treatment,” Expert Opinion on Emerging Drugs, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Daniel J. Clauw, Yvonne D’Arcy, Kevin Gebke, David Semel, Lynne Pauer, and Kim D. Jones, “Normalizing fibromyalgia as a chronic illness,” Postgraduate Medicine, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Christos Melidis, Susan L. Denham, and Michael E. Hyland, “A test of the adaptive network explanation of functional disorders using a machine learning analysis of symptoms,” Biosystems, 2017. View at Publisher · View at Google Scholar
  • Piercarlo Sarzi-Puttini, Fabiola Atzeni, Ignazio Francesco Masala, Fausto Salaffi, Joab Chapman, and Ernest Choy, “Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria?,” Autoimmunity Reviews, 2017. View at Publisher · View at Google Scholar
  • Adrián Pérez-Aranda, Alberto Barceló-Soler, Laura Andrés-Rodríguez, M. Teresa Peñarrubia-María, Raffaele Tuccillo, Gemma Borraz-Estruch, Javier García-Campayo, Albert Feliu-Soler, and Juan V. Luciano, “Description and narrative review of well-established and promising psychological treatments for fibromyalgia,” Mindfulness & Compassion, 2017. View at Publisher · View at Google Scholar
  • Dinesh Kumbhare, Sara Ahmed, Tori Sander, Liza Grosman-Rimon, and John Srbely, “A Survey of Physicians’ Knowledge and Adherence to the Diagnostic Criteria for Fibromyalgia,” Pain Medicine, 2017. View at Publisher · View at Google Scholar
  • Roland van Rensburg, Helgard Pieter Meyer, Sonia Anne Hitchcock, and Christian Edward Schuler, “Screening for Adult ADHD in Patients with Fibromyalgia Syndrome,” Pain Medicine, 2017. View at Publisher · View at Google Scholar
  • W. Häuser, F. Petzke, and M.-A. Fitzcharles, “Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews,” European Journal of Pain, 2017. View at Publisher · View at Google Scholar
  • Tess E Cooper, Sheena Derry, Philip J Wiffen, and R Andrew MooreCochrane Database of Systematic Reviews, 2017. View at Publisher · View at Google Scholar
  • K. Thieme, and D. C. Turk, “Leitlinien und EULAR-Empfehlungen für die Behandlung der Fibromyalgie,” Der Schmerz, vol. 31, no. 2, pp. 170–178, 2017. View at Publisher · View at Google Scholar
  • Nicholas Hylands-White, Rui V. Duarte, and Jon H. Raphael, “An overview of treatment approaches for chronic pain management,” Rheumatology International, vol. 37, no. 1, pp. 29–42, 2017. View at Publisher · View at Google Scholar
  • Leslie J. Crofford, “Fibromyalgia,” Kelley and Firestein's Textbook of Rheumatology, pp. 768–783.e3, 2017. View at Publisher · View at Google Scholar
  • Winfried Häuser, Jacob Ablin, Serge Perrot, and Mary-Ann Fitzcharles, “Management of fibromyalgia: Key messages from recent evidence-based guidelines,” Polskie Archiwum Medycyny Wewnetrznej, vol. 127, no. 1, pp. 47–56, 2017. View at Publisher · View at Google Scholar
  • Michelle Teo, Bindu Mohan, and Nelly D. Oelke, “Developing and Implementing a Community-Based Model of Care for Fibromyalgia: A Feasibility Study,” Pain Research and Management, vol. 2017, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Christina WH Cheng, Clara SM Wong, Grace KM Hui, Edmond KN Chung, and Steven HS Wong, “Fibromyalgia: is it a neuropathic pain?,” Pain Management, 2018. View at Publisher · View at Google Scholar
  • Amy Peterman, and Charlsie Myers, “Fibromyalgia,” Encyclopedia of Clinical Neuropsychology, pp. 1422–1426, 2018. View at Publisher · View at Google Scholar
  • Patrick Welsch, Kathrin Bernardy, Sheena Derry, R Andrew Moore, and Winfried Häuser, “Mirtazapine for fibromyalgia in adults,” Cochrane Database of Systematic Reviews, 2018. View at Publisher · View at Google Scholar
  • Arnav Agarwal, Yvgeniy Oparin, Lauren Glick, Mary-Ann Fitzcharles, Jonathan D. Adachi, Matthew D. Cooper, Lucas Gallo, Laura Wong, and Jason W. Busse, “Attitudes Toward and Management of Fibromyalgia,” JCR: Journal of Clinical Rheumatology, vol. 24, no. 5, pp. 243–249, 2018. View at Publisher · View at Google Scholar
  • Françoise Laroche, “La fibromyalgie : diagnostic positif, diagnostics différentiels et diagnostics associés,” Revue du Rhumatisme Monographies, 2018. View at Publisher · View at Google Scholar
  • Oliver M. D. Emrich, “Cannabis — keine Empfehlung bei Fibromyalgiesyndrom?,” Schmerzmedizin, vol. 34, no. 4, pp. 46–47, 2018. View at Publisher · View at Google Scholar
  • Aysun Genç, Suleyman Utku Çelik, Deniz Evcik, Ebru Düşünceli Atman, Atilla Halil Elhan, and Volkan Genç, “Balneotherapy is an alternative treatment for mastalgia; a randomized controlled trial,” European Journal of Integrative Medicine, vol. 19, pp. 100–104, 2018. View at Publisher · View at Google Scholar
  • Eline Coppens, Stefan Kempke, Peter Van Wambeke, Stephan Claes, Bart Morlion, Patrick Luyten, and Lukas Van Oudenhove, “Cortisol and Subjective Stress Responses to Acute Psychosocial Stress in Fibromyalgia Patients and Control Participants,” Psychosomatic Medicine, vol. 80, no. 3, pp. 317–326, 2018. View at Publisher · View at Google Scholar
  • Lesley M. Arnold, Ernest Choy, Daniel J. Clauw, Hiroshi Oka, Ed Whalen, David Semel, Lynne Pauer, and Lloyd Knapp, “An evidence-based review of pregabalin for the treatment of fibromyalgia,” Current Medical Research and Opinion, pp. 1–13, 2018. View at Publisher · View at Google Scholar
  • Massieh Moayedi, Tim V. Salomons, and Lauren Y. Atlas, “Pain Neuroimaging in Humans: a Primer for Beginners and Non-Imagers,” The Journal of Pain, 2018. View at Publisher · View at Google Scholar
  • Fred Davis, Mark Gostine, Bradley A. Roberts, Rebecca Risko, Joseph C. Cappelleri, and Alesia Sadosky, “Interpreting the Effectiveness of Opioids and Pregabalin for Pain Severity, Pain Interference, and Fatigue in Fibromyalgia Patients,” Pain Practice, 2018. View at Publisher · View at Google Scholar
  • Emma E. McGinty, Elizabeth A. Stuart, G. Caleb Alexander, Colleen L. Barry, Mark C. Bicket, and Lainie Rutkow, “Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing,” Implementation Science, vol. 13, no. 1, 2018. View at Publisher · View at Google Scholar
  • Winfried Häuser, Patrick Welsch, Petra Klose, Sheena Derry, Sebastian Straube, Philip J Wiffen, and R Andrew Moore, “Pharmacological therapies for fibromyalgia in adults - an overview of Cochrane Reviews,” Cochrane Database of Systematic Reviews, 2018. View at Publisher · View at Google Scholar
  • D. Russell, I. C. Álvarez Gallardo, I. Wilson, C. M. Hughes, G. W. Davison, B. Sañudo, and J. G. McVeigh, “‘Exercise to me is a scary word’: perceptions of fatigue, sleep dysfunction, and exercise in people with fibromyalgia syndrome—a focus group study,” Rheumatology International, 2018. View at Publisher · View at Google Scholar